Link to this page
Physician Data Query
Preferred Name | ribavirin | |
Synonyms |
Rebetol 1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide Viramide Virazid RIBA Virazole 1-beta-D-ribofuranosyl-1,2,4-triazolo-3-carboxamide RTCA ICN-1229 |
|
Definitions |
A synthetic nucleoside analogue of ribofuranosyl with antiviral activity. Ribavirin incorporates into viral nucleic acid, inhibits viral ribonucleic acid (RNA) synthesis, induces viral genome mutations, and inhibits normal viral replication. Ribavirin shows activity against a variety of RNA viruses, especially hepatitis C virus. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C807" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C807" NCI Thesaurus) |
|
ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000040325 |
|
altLabel |
Rebetol 1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide Viramide Virazid RIBA Virazole 1-beta-D-ribofuranosyl-1,2,4-triazolo-3-carboxamide RTCA ICN-1229
|
|
CAS Registry |
36791-04-5
|
|
Component of | ||
cui |
C0702029 C1622085 C1170576 C0035525 C0731013 C0702025
|
|
definition |
A synthetic nucleoside analogue of ribofuranosyl with antiviral activity. Ribavirin incorporates into viral nucleic acid, inhibits viral ribonucleic acid (RNA) synthesis, induces viral genome mutations, and inhibits normal viral replication. Ribavirin shows activity against a variety of RNA viruses, especially hepatitis C virus. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C807" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C807" NCI Thesaurus)
|
|
Legacy PDQ ID |
3167
|
|
LT |
TRD
|
|
NCI ID |
C807
|
|
notation |
CDR0000040325
|
|
NSC Code |
163039
|
|
ORIG STY |
Drug/agent
|
|
prefLabel |
ribavirin
|
|
tui |
T114 T121
|
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |